Like the wide-eyed toddlers who will stare in awe at their stack of holiday gifts this year, healthcare consumers certainly have a few surprises to get excited about as 2006 comes to a close.
Like the wide-eyed toddlers who will stare in awe at their stack of holiday gifts this year, healthcare consumers certainly have a few surprises to get excited about as 2006 comes to a close.
Talking about the uninsured moved toward doing something about it in 2006. Massachusetts and San Francisco adopted their own versions of universal coverage with variations of public and private initiatives. I was getting a little worried that raising awareness about uninsured Americans was as far as it would go. What a nice surprise that we're seeing real progress and getting past partisan politics.
RETAIL SALESMANSHIP
Perhaps the best consumer treat of all in 2006 was the retail price war involving generic drugs. Competitive market forces pushed a number of big retailers to offer low-cost and no-cost generic drugs in response to Wal-Mart's new $4 generic program, announced in September.
There's a lot of potential for discount stores, such as Target and Wal-Mart, and supermarkets, such as Giant Eagle and Wegmans, to lure in a greater share of pharmacy customers with deals on generics, data from a Wall Street Journal Online and Harris Interactive poll suggests. Respondents said they currently purchase their prescription drugs most often from chain drug stores (39%) but not as often from discount stores (13%) and supermarkets (the least popular at just 10%). Results also showed that 68% of survey respondents were open to choosing generic drugs over brands more often.
Each chain in the price war has its own generic offer from a few bucks to absolutely free, however, some chains include more drugs on their special price list than others. It will be up to the consumer to figure out which store has the best deal, which discount program is offering which drugs, and whether the bargain is attractive enough to switch their loyalty from the chain drug stores. According to the WSJ/Harris poll, 50% of respondents indicated they would indeed switch to the store that would give them a better deal on the drugs they need.
If consumers are willing to wait outside a discount retailer at 5 a.m. to get a bargain on an iPod, then certainly they must be willing to go there to save on their prescription drugs. I say: smart move, Big Retail. Discount generic pricing has reached a critical mass with more surprises yet to come.
Julie Miller is editor-in-chief of MANAGED HEALTHCARE EXECUTIVE. She can be reached at julie.miller@advanstar.com
A Conversation With Greg Baker, RPh, CEO of AffirmedRx
March 31st 2024Greg Baker, CEO of AffirmedRx, describes his early career, shares some of his critical opinions about the pharmacy benefit management (PBM) industry and how, in his view, his company is offering a better alternative.
Read More
David Calabrese of OptumRx Talks New Role, Market Insulin Prices and Other Topics 'On His Mind'
April 13th 2023In this month’s episode of the "What's On Your Mind podcast," Peter Wehrwein, managing editor of MHE connects with the now Chief Clinical Officer of OptumRx Integrated Pharmacies, David Calabrese. In this conversation, David touches on his transition in January as OptumRx’s former chief pharmacy officer and market president of health plans and PBMs to his new role as Chief Clinical Officer where he now focuses more on things such as specialty pharmacy to home delivery — with an overall goal of creating whole-patient care. Throughout the conversation, Calabrese also touched on the market’s hot topic of insulin prices and behavioral health services within the OptumRx community, among other topics.
Listen
Florida Gets the OK. But Will Drug Importation from Canada Actually Happen?
March 5th 2024Canadian health officials warn that maintaining a drug supply for Canadians is their priority. The staunch opposition of the U.S. pharmaceutical industry may also be an obstacle to imports from north of the border.
Read More
Briana Contreras, editor of Managed Healthcare Executive, spoke with Nancy Lurker, CEO and president of EyePoint Pharmaceuticals. Nancy shared a bit about EyePoint and how the organization’s innovative therapies are addressing patient needs through eye care, and most importantly, she addressed C-Suite positions like the CEO role. Nancy shared advice for those seeking to reach the CEO level, especially toward women in healthcare and other roles, and what it takes to run a biopharma company.
Listen
What Payers Need to Know As Retail Pharmacies Move Into Primary Care
September 6th 2023Healthcare beyond the doors of the doctor’s office has the potential to offer more care to more people. But payers need to think about how to ensure that care is consistent. Regardless of the setting, care decisions must be based on evidence-based content and supported with strong patient education.
Read More